Hemifacial hyperplasia

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:141145OMIM:133900Q67.4
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Hemifacial hyperplasia, also known as facial hemihypertrophy or hemifacial hypertrophy, is a rare congenital condition characterized by asymmetric overgrowth of one side of the face. The condition involves enlargement of both soft tissues and bony structures on the affected side, leading to noticeable facial asymmetry. Structures that may be affected include the maxilla, mandible, teeth, tongue (hemimacroglossia), lips, cheeks, ears, and overlying skin and subcutaneous tissues. The degree of asymmetry can range from mild, barely perceptible differences to significant disfigurement that impacts function and appearance. Hemifacial hyperplasia may occur as an isolated finding or as part of broader overgrowth syndromes such as Beckwith-Wiedemann syndrome, Proteus syndrome, or other segmental overgrowth conditions. When isolated, the cause is often unknown, though somatic mosaicism for growth-promoting genetic mutations has been implicated in some cases. Dental abnormalities are common and may include premature eruption, enlarged teeth (macrodontia), and malocclusion on the affected side. In some cases, there may be associated functional issues including difficulties with chewing, speech, and dental alignment. Treatment is primarily supportive and symptomatic, tailored to the severity of the asymmetry and functional impairment. Orthodontic management is frequently required to address dental and occlusal abnormalities. Surgical interventions, including orthognathic surgery, soft tissue reduction, and reconstructive procedures, may be considered to improve facial symmetry and function, typically after skeletal growth is complete. A multidisciplinary approach involving craniofacial surgeons, orthodontists, dentists, and other specialists is recommended for optimal management. Regular monitoring during childhood is important to track the progression of asymmetry during growth periods.

Also known as:

Clinical phenotype terms— hover any for plain English:

Hemifacial hypertrophyHP:0005323MacrodontiaHP:0001572Deviated nasal septumHP:0004411HemimacroglossiaHP:0100875Impaired masticationHP:0005216Airway obstructionHP:0006536Unilateral deafnessHP:0009900Open biteHP:0010807Unilateral sensorineural hearing impairmentHP:0025797Jaw painHP:0040264
Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Hemifacial hyperplasia.

View clinical trials →

No actively recruiting trials found for Hemifacial hyperplasia at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Hemifacial hyperplasia community →

No specialists are currently listed for Hemifacial hyperplasia.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Hemifacial hyperplasia.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Hemifacial hyperplasiaForum →

No community posts yet. Be the first to share your experience with Hemifacial hyperplasia.

Start the conversation →

Latest news about Hemifacial hyperplasia

No recent news articles for Hemifacial hyperplasia.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Hemifacial hyperplasia

What is Hemifacial hyperplasia?

Hemifacial hyperplasia, also known as facial hemihypertrophy or hemifacial hypertrophy, is a rare congenital condition characterized by asymmetric overgrowth of one side of the face. The condition involves enlargement of both soft tissues and bony structures on the affected side, leading to noticeable facial asymmetry. Structures that may be affected include the maxilla, mandible, teeth, tongue (hemimacroglossia), lips, cheeks, ears, and overlying skin and subcutaneous tissues. The degree of asymmetry can range from mild, barely perceptible differences to significant disfigurement that impacts

How is Hemifacial hyperplasia inherited?

Hemifacial hyperplasia follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Hemifacial hyperplasia typically begin?

Typical onset of Hemifacial hyperplasia is neonatal. Age of onset can vary across affected individuals.